Minerva
Loss of fingerprints secondary to palmoplantar erythrodysesthesia in a patient on capecitabine chemotherapy
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6023 (Published 25 November 2015) Cite this as: BMJ 2015;351:h6023
- Sara Lightowlers, speciality registrar in clinical oncology,
- Rubin Soomal, consultant clinical oncologist
- 1Department of Oncology, Ipswich Hospital, Ipswich IP4 5PD, UK
- lightowlers{at}doctors.org.uk
A 47 year old man on oxaliplatin and capecitabine chemotherapy developed dryness and erythema of the palms of his hands. He noticed he was unable …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.